Immunis.AI
Royal Oak
About Immunis.AI
Immunis AI is the developer of a non-invasive blood-based immunogenomic platform. The startup performs detailed genomic analysis of patient blood samples to understand diseases that individuals may be harbouring and the body's immune response to those diseases. The platform's initial focus is on oncology, with plans to expand to other diseases and treatments in the future.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Last round: Series Unknown (Sep 2021)
- Website: immunis.ai
- Phone: +1 248 918 0468
Industries & Categories
Artificial Intelligence (AI), Health Care, Health Diagnostics, Wellness
Social Profiles
Canonical: https://fsome.com/organization/immunis-ai-2683043 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.